share_log

Avidity Biosciences(RNA.US) Director Sells US$542.21K in Common Stock

moomoo News ·  Apr 3 21:07

$Avidity Biosciences (RNA.US)$ Director LEVIN ARTHUR A sold 20,000 shares of Common Stock on Apr 3, 2024 at an average price of $27.1107 for a total value of $542.21K.

1712192851191614773.png

What is statement of changes in beneficial ownership of securities?

It is a requirement under federal securities laws that mandates individuals, including officers, directors, and those who hold more than 10% of any class of a company's securities (collectively known as "insiders"), to report their purchases, sales, and holdings of their company's securities by submitting Forms 3, 4, and 5.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment